Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	648.3	466.39	498.72	437.03	336.55	430.86
Short-Term Investments	-	263.97	322.21	342.83	-	-
Trading Asset Securities	18.48	-	-	-	-	52.2
Cash & Short-Term Investments	666.78	730.35	820.93	779.86	336.55	483.06
Cash Growth	49.31%	-11.03%	5.27%	131.72%	-30.33%	159.83%
Accounts Receivable	265.45	262.44	261.25	297.24	232.03	191.8
Other Receivables	22.75	54.72	27.59	25.22	26.26	13.89
Receivables	288.2	317.16	288.84	322.46	258.29	205.69
Inventory	281.68	232.07	220.37	200.57	193.5	148.18
Other Current Assets	51.11	54.1	41.26	33	41.41	29.53
Total Current Assets	1,288	1,334	1,371	1,336	829.76	866.46
Property, Plant & Equipment	893.32	911.18	888.73	737.85	584.72	442.18
Long-Term Investments	12.93	13.84	8.53	8.69	9.83	5.5
Goodwill	25.15	25.15	40.67	127.13	127.13	136.59
Other Intangible Assets	107.16	101.63	98.08	94.51	90.51	89.38
Long-Term Accounts Receivable	12.34	4.12	5.59	-	-	-
Long-Term Deferred Tax Assets	34.45	29.19	18.13	25	10.48	6.03
Long-Term Deferred Charges	37.93	39.81	40.85	25.91	31.85	30.13
Other Long-Term Assets	116.9	40.21	62.43	83.97	35.24	30.9
Total Assets	2,528	2,499	2,534	2,439	1,720	1,607
Accounts Payable	219.68	206.49	246.8	221.26	178.44	133.13
Accrued Expenses	13.19	43.5	38.87	49.57	37.35	57.31
Short-Term Debt	159.43	188.14	220.41	132.64	130.66	105.5
Current Portion of Long-Term Debt	247.27	40.7	50.37	14.55	8.06	-
Current Portion of Leases	-	6.65	6.45	5.95	4.47	-
Current Income Taxes Payable	4.37	1.98	3.08	3.98	3.37	7.17
Current Unearned Revenue	50.06	43.75	69.39	76.01	48.08	47.65
Other Current Liabilities	102.04	144.61	135.34	99.43	86.77	43.89
Total Current Liabilities	796.05	675.82	770.7	603.39	497.2	394.65
Long-Term Debt	277.18	388.05	284.16	252.97	205.21	162.21
Long-Term Leases	19.1	22.19	23.61	21.46	8.12	-
Long-Term Unearned Revenue	135.94	106.94	50.3	45.38	9.32	10.4
Long-Term Deferred Tax Liabilities	12.79	14.72	14.87	13.48	7.25	7.07
Other Long-Term Liabilities	-	-	1.81	-	0.03	-
Total Liabilities	1,241	1,208	1,145	936.68	727.13	574.33
Common Stock	264.58	264.58	264.58	175.79	146.09	146.09
Additional Paid-In Capital	408.06	408.04	408.03	504.38	-	15.83
Retained Earnings	504.7	513.04	584.48	684.82	698.15	701.16
Treasury Stock	-20.01	-20.01	-	-	-	-
Comprehensive Income & Other	54.58	53.04	53.81	51.09	49.64	54.85
Total Common Equity	1,212	1,219	1,311	1,416	893.89	917.93
Minority Interest	74.99	72.43	78.05	86.17	98.49	114.9
Shareholders' Equity	1,287	1,291	1,389	1,502	992.38	1,033
Total Liabilities & Equity	2,528	2,499	2,534	2,439	1,720	1,607
Total Debt	702.98	645.72	584.99	427.57	356.52	267.71
Net Cash (Debt)	-36.21	84.63	235.94	352.29	-19.97	215.35
Net Cash Growth	-	-64.13%	-33.03%	-	-	12617.43%
Net Cash Per Share	-0.14	0.32	0.89	1.35	-0.09	0.98
Filing Date Shares Outstanding	261.61	261.6	264.58	263.68	262.22	219.13
Total Common Shares Outstanding	261.61	261.6	264.58	263.68	219.14	219.13
Working Capital	491.71	657.87	600.7	732.5	332.56	471.81
Book Value Per Share	4.63	4.66	4.95	5.37	4.08	4.19
Tangible Book Value	1,080	1,092	1,172	1,194	676.25	691.96
Tangible Book Value Per Share	4.13	4.17	4.43	4.53	3.09	3.16
Buildings	-	582.36	308.84	244.21	216.58	224.73
Machinery	-	448.39	418.44	398.3	361.28	283.82
Construction In Progress	-	127.92	365.74	263.45	155.7	71.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.